Inhaled therapies in patients with moderate COPD in clinical practice: current thinking

Area of Science:

• Pulmonology
• Respiratory Medicine
• Clinical Practice

Background:

• Chronic Obstructive Pulmonary Disease (COPD) is a complex condition with significant early-stage burden, including breathlessness impacting exercise capacity and mortality.
• Current clinical practices for COPD management often deviate from established guidelines.
• Effective management strategies are crucial for symptom reduction, lung function preservation, and preventing exacerbations.

Purpose of the Study:

• To review current evidence and expert opinion on managing moderate COPD.
• To discuss the impact of symptoms, the role of physical activity, and the benefits of dual bronchodilation.
• To evaluate the limited evidence for inhaled corticosteroids in moderate COPD.

Main Methods:

• Literature review of scientific evidence.
• Analysis of expert opinion.
• Focus on moderate COPD management strategies.

Main Results:

• Dual bronchodilation is emphasized for maximizing airflow and improving patient outcomes in COPD.
• Physical activity can positively influence disease outcomes.
• Evidence for inhaled corticosteroids in moderate COPD is limited.

Conclusions:

• Maximizing bronchodilation through dual-bronchodilator therapy is crucial for enhancing patient-related outcomes in COPD.
• Inhaled corticosteroid withdrawal may be possible in specific COPD patient groups with optimized bronchodilation.
• Aligning clinical practice with guidelines is essential for optimal COPD care.